SYNC - YOGA: Influence of Yoga in Patients With Neurocardiogenic Syncope

Sponsor
Dhanunjaya Lakkireddy, MD, FACC (Other)
Overall Status
Completed
CT.gov ID
NCT01695525
Collaborator
(none)
8
1
1
33
0.2

Study Details

Study Description

Brief Summary

Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping skills.

It has been established that practice of Yoga could relieve stress and anxiety. In a different study, they also found that Yoga positively influences cardiovascular function by decreasing the heart rate and blood pressure. The main objective of Yoga is to achieve control over the autonomic nervous system and able to control functions like heart rate, blood pressure and respiratory rate.

Based on the findings that Yoga relieves stress and reduces heart rate, the investigators propose to study if Yoga can decrease the frequency of NCS and also reduce the symptoms associated with these episodes.

Condition or Disease Intervention/Treatment Phase
  • Other: Yoga
Early Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Neurocardiogenic Syncope and the Role That Yoga Plays in People With Autonomic Dysfunction
Study Start Date :
Jun 1, 2012
Actual Primary Completion Date :
Mar 1, 2015
Actual Study Completion Date :
Mar 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Yoga

Participants will be asked to practice Yoga 3 times per week at a minimum, and daily at a maximum. Participants will receive training in different Yoga techniques including breathing exercises, postures and meditation. Participants will be asked to practice 1 hour Yoga sessions comprised of breathing exercises, postures and meditation.

Other: Yoga
Includes breathing exercises, postures, and meditation. Participant practices yoga at their home a minimum of 3 times per week for 1 hour per time. Participation can last for up to 1 year.

Outcome Measures

Primary Outcome Measures

  1. Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) [Baseline to 3 Months]

    Differences in the incidence of syncopal spells pre and post Yoga.

  2. Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) [Baseline to 1 Year]

    Differences in the incidence of syncopal spells pre and post Yoga.

  3. Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) [Baseline to 1 Year]

    Differences in the incidence of syncopal symptoms pre and post Yoga.

Secondary Outcome Measures

  1. Change in Heart Health [3 Months, 1 Year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of recurrent Neurocardiogenic syncope

  • At least one episode of syncope or pre-syncopal event in the last 3 months prior to enrollment

Exclusion Criteria:
  • Previously established diagnosis of any psychiatric illness.

  • Previous history of Coronary Artery Disease, myocardial infarction, congestive heart failure, carotid sinus hypersensitivity

  • Established diagnosis of tachy and/or brady arrhythmias, except cardioinhibiotry neurocardiogenic syncope.

  • History of pacemaker, ICD or CRT-D implantation.

  • Other conditions where Yoga should be avoided are:

  1. Pregnant women

  2. Subjects with untreated or uncontrolled high blood pressure

  3. Subjects with past history of Pnuemothorax.

  4. Subjects with severe cervical spondylitis and cervical, thoracic or lumbar disc prolapse.

  5. Subjects with carotid stenosis

  6. Subjects with history of psychosis (evidence of acute episodes with deep and prolonged meditation) or substance abuse.

  7. Subjects with the history of epilepsy ( evidence of acute episodes with deep and prolonged meditation)

  8. Subjects with glaucoma

  9. Subjects with history of Total Hip Replacement.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Kansas Medical Center Kansas City Kansas United States 66160

Sponsors and Collaborators

  • Dhanunjaya Lakkireddy, MD, FACC

Investigators

  • Principal Investigator: Dhanunjaya Lakkireddy, MD, FACC, University of Kansas Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dhanunjaya Lakkireddy, MD, FACC, Professor of Medicine, University of Kansas Medical Center
ClinicalTrials.gov Identifier:
NCT01695525
Other Study ID Numbers:
  • 12945
First Posted:
Sep 28, 2012
Last Update Posted:
Jun 30, 2015
Last Verified:
Jun 1, 2015
Keywords provided by Dhanunjaya Lakkireddy, MD, FACC, Professor of Medicine, University of Kansas Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2015